Conflict of interest in oncology publications: A survey of disclosure policies and statements

Aaron S. Kesselheim, Joy Lee, Jerry Avorn, Amber Servi, William H. Shrank, Niteesh K. Choudhry

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

BACKGROUND: Disclosure of conflicts of interest in biomedical research is receiving increased attention. The authors sought to define current disclosure policies and how they relate to disclosure statements provided by authors in major oncology journals. METHODS: The authors identified all oncology journals listed in the Thomson Institute for Scientific Information and sought their policies on conflict-of-interest disclosure. For a subset of journals with an Impact Factor >2.0, they catalogued the number and type of articles and the details of the published disclosures in all papers from the 2 most recent issues. RESULTS: Disclosure policies were provided by 112 of 131 journals (85%); 99 (88%) of these requested that authors disclose conflicts of interest (mean Impact Factor for these journals: 4.6), whereas the remaining 13 (12%) did not (mean Impact Factor: 2.9). Ninety-three journals (94%) required financial disclosure, and 42 (42%) also sought nonfinancial disclosures. For a subset of 52 higher-impact journals (Impact Factor >2.0), we reviewed 1734 articles and identified published disclosures in 51 journals (98%). Many of these journals (31 of 51, 61%) included some disclosure statement in >90% of their articles. Among 27 journals that published editorials/commentaries, only 14 (52%) included disclosures with such articles. There was no publication of any nonfinancial conflicts of interest in any article reviewed. CONCLUSIONS: Disclosure policies and the very definition of conflict of interest varied considerably among journals. Although most journals had some policy in this area, a substantial proportion did not publish disclosure statements consistently, with deficiencies particularly among editorials and commentaries.

Original languageEnglish (US)
Pages (from-to)188-195
Number of pages8
JournalCancer
Volume118
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Conflict of Interest
Disclosure
Publications
Journal Impact Factor
Surveys and Questionnaires
Biomedical Research

Keywords

  • clinical oncology
  • conflict of interest
  • disclosure
  • publishing

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kesselheim, A. S., Lee, J., Avorn, J., Servi, A., Shrank, W. H., & Choudhry, N. K. (2012). Conflict of interest in oncology publications: A survey of disclosure policies and statements. Cancer, 118(1), 188-195. https://doi.org/10.1002/cncr.26237

Conflict of interest in oncology publications : A survey of disclosure policies and statements. / Kesselheim, Aaron S.; Lee, Joy; Avorn, Jerry; Servi, Amber; Shrank, William H.; Choudhry, Niteesh K.

In: Cancer, Vol. 118, No. 1, 01.01.2012, p. 188-195.

Research output: Contribution to journalReview article

Kesselheim, AS, Lee, J, Avorn, J, Servi, A, Shrank, WH & Choudhry, NK 2012, 'Conflict of interest in oncology publications: A survey of disclosure policies and statements', Cancer, vol. 118, no. 1, pp. 188-195. https://doi.org/10.1002/cncr.26237
Kesselheim, Aaron S. ; Lee, Joy ; Avorn, Jerry ; Servi, Amber ; Shrank, William H. ; Choudhry, Niteesh K. / Conflict of interest in oncology publications : A survey of disclosure policies and statements. In: Cancer. 2012 ; Vol. 118, No. 1. pp. 188-195.
@article{6390dd0d2ec84c609756b3f9b05f55ca,
title = "Conflict of interest in oncology publications: A survey of disclosure policies and statements",
abstract = "BACKGROUND: Disclosure of conflicts of interest in biomedical research is receiving increased attention. The authors sought to define current disclosure policies and how they relate to disclosure statements provided by authors in major oncology journals. METHODS: The authors identified all oncology journals listed in the Thomson Institute for Scientific Information and sought their policies on conflict-of-interest disclosure. For a subset of journals with an Impact Factor >2.0, they catalogued the number and type of articles and the details of the published disclosures in all papers from the 2 most recent issues. RESULTS: Disclosure policies were provided by 112 of 131 journals (85{\%}); 99 (88{\%}) of these requested that authors disclose conflicts of interest (mean Impact Factor for these journals: 4.6), whereas the remaining 13 (12{\%}) did not (mean Impact Factor: 2.9). Ninety-three journals (94{\%}) required financial disclosure, and 42 (42{\%}) also sought nonfinancial disclosures. For a subset of 52 higher-impact journals (Impact Factor >2.0), we reviewed 1734 articles and identified published disclosures in 51 journals (98{\%}). Many of these journals (31 of 51, 61{\%}) included some disclosure statement in >90{\%} of their articles. Among 27 journals that published editorials/commentaries, only 14 (52{\%}) included disclosures with such articles. There was no publication of any nonfinancial conflicts of interest in any article reviewed. CONCLUSIONS: Disclosure policies and the very definition of conflict of interest varied considerably among journals. Although most journals had some policy in this area, a substantial proportion did not publish disclosure statements consistently, with deficiencies particularly among editorials and commentaries.",
keywords = "clinical oncology, conflict of interest, disclosure, publishing",
author = "Kesselheim, {Aaron S.} and Joy Lee and Jerry Avorn and Amber Servi and Shrank, {William H.} and Choudhry, {Niteesh K.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1002/cncr.26237",
language = "English (US)",
volume = "118",
pages = "188--195",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Conflict of interest in oncology publications

T2 - A survey of disclosure policies and statements

AU - Kesselheim, Aaron S.

AU - Lee, Joy

AU - Avorn, Jerry

AU - Servi, Amber

AU - Shrank, William H.

AU - Choudhry, Niteesh K.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - BACKGROUND: Disclosure of conflicts of interest in biomedical research is receiving increased attention. The authors sought to define current disclosure policies and how they relate to disclosure statements provided by authors in major oncology journals. METHODS: The authors identified all oncology journals listed in the Thomson Institute for Scientific Information and sought their policies on conflict-of-interest disclosure. For a subset of journals with an Impact Factor >2.0, they catalogued the number and type of articles and the details of the published disclosures in all papers from the 2 most recent issues. RESULTS: Disclosure policies were provided by 112 of 131 journals (85%); 99 (88%) of these requested that authors disclose conflicts of interest (mean Impact Factor for these journals: 4.6), whereas the remaining 13 (12%) did not (mean Impact Factor: 2.9). Ninety-three journals (94%) required financial disclosure, and 42 (42%) also sought nonfinancial disclosures. For a subset of 52 higher-impact journals (Impact Factor >2.0), we reviewed 1734 articles and identified published disclosures in 51 journals (98%). Many of these journals (31 of 51, 61%) included some disclosure statement in >90% of their articles. Among 27 journals that published editorials/commentaries, only 14 (52%) included disclosures with such articles. There was no publication of any nonfinancial conflicts of interest in any article reviewed. CONCLUSIONS: Disclosure policies and the very definition of conflict of interest varied considerably among journals. Although most journals had some policy in this area, a substantial proportion did not publish disclosure statements consistently, with deficiencies particularly among editorials and commentaries.

AB - BACKGROUND: Disclosure of conflicts of interest in biomedical research is receiving increased attention. The authors sought to define current disclosure policies and how they relate to disclosure statements provided by authors in major oncology journals. METHODS: The authors identified all oncology journals listed in the Thomson Institute for Scientific Information and sought their policies on conflict-of-interest disclosure. For a subset of journals with an Impact Factor >2.0, they catalogued the number and type of articles and the details of the published disclosures in all papers from the 2 most recent issues. RESULTS: Disclosure policies were provided by 112 of 131 journals (85%); 99 (88%) of these requested that authors disclose conflicts of interest (mean Impact Factor for these journals: 4.6), whereas the remaining 13 (12%) did not (mean Impact Factor: 2.9). Ninety-three journals (94%) required financial disclosure, and 42 (42%) also sought nonfinancial disclosures. For a subset of 52 higher-impact journals (Impact Factor >2.0), we reviewed 1734 articles and identified published disclosures in 51 journals (98%). Many of these journals (31 of 51, 61%) included some disclosure statement in >90% of their articles. Among 27 journals that published editorials/commentaries, only 14 (52%) included disclosures with such articles. There was no publication of any nonfinancial conflicts of interest in any article reviewed. CONCLUSIONS: Disclosure policies and the very definition of conflict of interest varied considerably among journals. Although most journals had some policy in this area, a substantial proportion did not publish disclosure statements consistently, with deficiencies particularly among editorials and commentaries.

KW - clinical oncology

KW - conflict of interest

KW - disclosure

KW - publishing

UR - http://www.scopus.com/inward/record.url?scp=83855162904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83855162904&partnerID=8YFLogxK

U2 - 10.1002/cncr.26237

DO - 10.1002/cncr.26237

M3 - Review article

C2 - 21717432

AN - SCOPUS:83855162904

VL - 118

SP - 188

EP - 195

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -